AbbVie Splits from Abbott; Humira Is a Top Priority
AbbVie Inc. launched Wednesday as an independent biopharma, splitting from Abbott in a plan initially disclosed in October 2011. AbbVie took several dozen marketed products and a portfolio of late-stage compounds in immunology, neuroscience and oncology.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST